| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/APT.13006 |
| P698 | PubMed publication ID | 25348873 |
| P2093 | author name string | T Itoh | |
| C Sakamoto | |||
| S Futagami | |||
| P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia | Q31811118 | ||
| Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia | Q33805605 | ||
| Review article: Helicobacter pylori, mucosal inflammation and symptom perception--new insights into an old hypothesis | Q34327967 | ||
| The eosinophil | Q34503956 | ||
| Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori | Q34531425 | ||
| Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate | Q34532392 | ||
| Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness | Q34627613 | ||
| Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. | Q34634528 | ||
| Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia | Q35181513 | ||
| Changes in enteric neural circuitry and smooth muscle in the inflamed and infected gut. | Q35738975 | ||
| Inflammation as a basis for functional GI disorders. | Q35868640 | ||
| Review article: the overlap between functional dyspepsia and irritable bowel syndrome -- a tale of one or two disorders? | Q35936955 | ||
| American gastroenterological association technical review on the evaluation of dyspepsia | Q36312272 | ||
| Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. | Q36365651 | ||
| Allergy and intestinal dysmotility--evidence of genuine causal linkage? | Q36629349 | ||
| Role of infection in irritable bowel syndrome | Q36713061 | ||
| Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study | Q37684322 | ||
| Acute gastroenteritis and the risk of functional dyspepsia: a systematic review and meta-analysis | Q38109760 | ||
| Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia | Q39390618 | ||
| The impact of post-infectious functional gastrointestinal disorders and symptoms on the health-related quality of life of US military personnel returning from deployment to the Middle East | Q39534347 | ||
| Helicobacter pyloriInfection and Non-Ulcer Dyspepsia: The Effect of Treatment with Colloidal Bismuth Subcitrate | Q42120417 | ||
| Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood | Q42222711 | ||
| The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia | Q43159208 | ||
| Risk of functional gastrointestinal disorders in U.S. military following self-reported diarrhea and vomiting during deployment | Q43522303 | ||
| Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia | Q43731491 | ||
| Effect of 2,4,6-trinitrobenzenesulphonic acid (TNBS)-induced ileitis on the motor function of non-inflamed rat gastric fundus. | Q43750389 | ||
| Clinical and pathophysiological characteristics of acute-onset functional dyspepsia | Q44021724 | ||
| Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome | Q44520650 | ||
| Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study | Q44793336 | ||
| Intestinal immune activation in presumed post-infectious functional dyspepsia. | Q44827731 | ||
| Postinfectious gastrointestinal disorders following norovirus outbreaks | Q45072542 | ||
| Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat | Q45198367 | ||
| Growth hormone treatment and risk of recurrence or development of secondary neoplasms in survivors of pediatric brain tumors. | Q45905861 | ||
| Does Helicobacter pylori-induced inflammation of gastric mucosa determine the severity of symptoms in functional dyspepsia? | Q46153874 | ||
| Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role? | Q46691647 | ||
| Post-infectious functional gastrointestinal disorders in children | Q50061795 | ||
| Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. | Q50088937 | ||
| Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. | Q51035370 | ||
| Psychometric scores and persistence of irritable bowel after infectious diarrhoea. | Q51117034 | ||
| Gastrointestinal motility disorders in patients with inactive Crohn's disease. | Q51572730 | ||
| Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. | Q54269295 | ||
| Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection | Q59297432 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 177-188 | |
| P577 | publication date | 2014-10-27 | |
| P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
| P1476 | title | Systematic review with meta-analysis: post-infectious functional dyspepsia | |
| P478 | volume | 41 |
| Q35992014 | Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures |
| Q26777534 | Dysbiotic infection in the stomach |
| Q40970757 | Eosinophilic Esophagitis in Children and Adolescents with Abdominal Pain: Comparison with EoE-Dysphagia and Functional Abdominal Pain. |
| Q59795000 | Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler's diarrhea: a prospective cohort study protocol |
| Q30234615 | Functional Dyspepsia: Advances in Diagnosis and Therapy |
| Q100530208 | Functional dyspepsia |
| Q47691689 | Functional dyspepsia and duodenal eosinophilia: A new model |
| Q40281641 | Functional dyspepsia is associated with duodenal eosinophilia in an Australian paediatric cohort. |
| Q26751475 | Functional dyspepsia: new insights into pathogenesis and therapy |
| Q46258930 | Gastric microbiota: tracing the culprit |
| Q40061346 | Giardia lamblia infection increases risk of chronic gastrointestinal disorders. |
| Q28396111 | Global Epidemiology of Campylobacter Infection |
| Q55190074 | Heat shock protein 70 protects mouse against post-infection irritable bowel syndrome via up-regulating intestinal γδ T cell's Th17 response. |
| Q60909774 | Microbiome-The Missing Link in the Gut-Brain Axis: Focus on Its Role in Gastrointestinal and Mental Health |
| Q30240631 | Norovirus Regulation by Host and Microbe |
| Q38909322 | Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial |
| Q26829363 | Profile of rifaximin and its potential in the treatment of irritable bowel syndrome |
| Q64282500 | Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center |
| Q55527145 | Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders. |
| Q55555758 | Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift. |
| Q56366234 | Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome |
| Q58799099 | System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of Zhi-zhu Wan for Functional Dyspepsia |
| Q38420105 | Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea |
| Q48504199 | The Risk of Chronic Gastrointestinal Disorders Following Acute Infection with Intestinal Parasites |
| Q34486007 | The role of mast cells in functional GI disorders. |
| Q54956782 | Therapeutic Effects of Low-dose Bismuth Subcitrate on Symptoms and Health-related Quality of Life in Adult Patients with Irritable Bowel Syndrome: A Clinical Trial. |
Search more.